{"pageContent": "Purpose: While the dissemination of robotic prostatectomy and intensity modulated radiotherapy may fuel the increased use of prostatectomy and radiotherapy, these new technologies may also have spillover effects related to diagnostic testing for prostate cancer. Therefore, we examined the association of regional technology penetration with the receipt of prostate specific antigen testing and prostate biopsy.", "metaData": {"source": "Genetic testing in prostate cancer management: Considerations informing primary care\nhttps://pubmed.ncbi.nlm.nih.gov/35201622/"}}